Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Antiviral Research|November 13, 2010
Sensitivity of seven HIV subtyping tools differs among subtypes/recombinants in the Spanish cohort of naïve HIV-infected patients (CoRIS)Gonzalo Yebra, Miguel de Mulder, Leticia Martín, et al.
Journal of Clinical Microbiology|December 14, 2011
Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naïve HIV-infected patients (CoRIS) are due to recombinant virusesGonzalo Yebra, Miguel de Mulder, Leticia Martín, et al.
Antiviral Therapy|May 7, 2013
Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevirJosé M Benito, Clara Sánchez-Parra, Ivana Maida, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2006
Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapyPablo Barreiro, Jorge del Romero, Manuel Leal, et al.
Sexually Transmitted Infections|November 23, 2014
Misconceptions about HIV infection in Kinshasa (Democratic Republic of Congo): a case-control study on knowledge, attitudes and practicesSilvia Carlos, Miguel Ángel Martínez-González, Eduardo Burgueño, et al.
AIDS (London, England)|March 6, 2009
Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovirPablo Labarga, Pablo Barreiro, Luz Martin-Carbonero, et al.
AIDS Research and Human Retroviruses|April 10, 2010
Preemptive erythropoietin plus high ribavirin doses to increase rapid virological responses in HIV patients treated for chronic hepatitis CEugenia Vispo, Pablo Labarga, Josep M Guardiola, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 25, 2012
Differences in virological response to peginterferon-α plus ribavirin in HIV-positive patients coinfected with HCV subtypes 1a or 1bNorma I Rallón, Juan A Pineda, Vincent Soriano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 10, 2009
Rate and timing of hepatitis C virus relapse after a successful course of pegylated interferon plus ribavirin in HIV-infected and HIV-uninfected patientsJosé Medrano, Pablo Barreiro, Salvador Resino, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2009
Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997-2006Santiago Pérez Cachafeiro, Julia Del Amo, Jose A Iribarren, et al.
Pageof 11